Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Hunter C. Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Kayden Lee - $8.90M of RYTM open-market activity in the last 12 months
- Yann Mazabraud - $6.62M of RYTM open-market activity in the last 12 months
- Joseph Shulman - $5.44M of RYTM open-market activity in the last 12 months
- Lynn A. Tetrault - $3.71M of RYTM open-market activity in the last 12 months
- Pamela J. Cramer - $2.62M of RYTM open-market activity in the last 12 months
- Christopher Paul German - $931K of RYTM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Hunter C. Smith?
Hunter C. Smith is a corporate insider, tracked as Chief Financial Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Hunter C. Smith last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 9 filings going back to 2025.
Has Hunter C. Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 28 open-market sales ($8.31M) across all tracked filings.
Where can I see all of Hunter C. Smith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Hunter C. Smith and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
